{"id":"NCT00885378","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2.5 mg Saxagliptin, Twice Daily, in Combination With Metformin IR in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin IR Alone","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2010-02","completion":"2010-02","firstPosted":"2009-04-22","resultsPosted":"2011-12-16","lastUpdate":"2015-06-01"},"enrollment":166,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Saxagliptin plus metformin IR","otherNames":["BMS-477118","Onglyza"]},{"type":"DRUG","name":"Placebo plus metformin IR","otherNames":[]}],"arms":[{"label":"Saxagliptin plus metformin IR","type":"ACTIVE_COMPARATOR"},{"label":"Placebo plus metformin IR","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the reduction in hemoglobin A1C (A1C) for participants taking saxagliptin in combination with metformin immediate release (IR) versus metformin IR alone.","primaryOutcome":{"measure":"Mean Hemoglobin A1C (A1c) and Change From Baseline to Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Saxagliptin 2.5 mg + Metformin Immediate Release (IR)","deltaMin":7.92,"sd":0.11},{"arm":"Placebo + Metformin IR","deltaMin":7.97,"sd":0.09}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0063"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":41,"countries":["United States","Germany","Hungary","Puerto Rico"]},"refs":{"pmids":["24565221"],"seeAlso":["http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":86},"commonTop":[]}}